February 2024 FDA Recall Oseltamivir Phosphate by Amneal Pharmaceuticals Of New York, Llc
D-0327-2024 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Amneal Pharmaceuticals Of New York, Llc on February 13, 2024 for the product Oseltamivir Phosphate. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0327-2024

Reason for Recall
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Initiated
02-13-2024
Reported
02-28-2024
Quantity
46,037 Bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
93959
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Amneal Pharmaceuticals of New York, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA
Termination Date About Termination Date
Date that FDA officially terminated the recall.
02-14-2025
Product Description About Product Description
Full technical description of the product.
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6

Batch or Lot Expiration Information

Lot# BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024

Affected Packages Involved in this Recall

69238-1273-6 Oseltamivir Phosphate